What is Medicare & Medicaid fraud?

Learn about the most common ways that companies and individuals defraud the US government healthcare programs.

 

Who can become a Medicare & Medicaid whistleblower?

Do you have information about Medicare or Medicaid fraud? Find out if you can become a healthcare fraud whistleblower and receive a financial reward.

Receiving a financial reward.

Medicare & Medicaid whistleblowers may be entitled to a significant financial reward for coming forward. Learn about receiving a financial reward for your information here.

Medicaid Fraud News

The Department of Justice (DOJ) issued a press release announcing a civil and criminal settlement worth $161 million with Caremark Inc. The Inspector General of the U.S. Department of Health and Human Services led the investigation and was assisted by the FBI.

Read more...
Aventis Pays More Than $190 Million to Settle Drug Pricing Fraud Matters
Print E-mail

In a September 10, 2007 press release, the United States Department of Justice revealed the details of a $190 million settlement it had reached with Aventis Pharmaceuticals, now known as Sanofi-Aventis U.S. Inc and Sanofi-Aventis U.S. LLC.

Aventis accused of committing acts of Medicaid Fraud by DOJ

The giant pharmaceutical company agreed to pay three parties: the US government, The District of Columbia, and several states. This settlement resolves allegations that Aventis engaged in pricing practices that resulted in government organizations overpaying for drugs made by the company.

The settlement centered on the company’s prices charged for its popular drug, Anzemet. This drug helps combat the nausea that many cancer patients suffer when undergoing oncology and cancer treatment.

The government alleged infractions prohibited by the False Claims Act in charging the company. They said Aventis fraudulently set prices for Anzemet, knowing full well that federal health programs would set reimbursements to the company on those inflated prices.

The US government said that Aventis knowingly caused false claim submissions to the federal government because its charges were based on the fraudulent, inflated pricing. As a result, the company’s earnings for the drug were positively impacted. Assistant Attorney General Peter D. Keisler said “The Justice Department will continue to hold drug companies accountable for fraudulent pricing schemes designed to give windfalls to drug companies and doctors at the expense of federal health care programs for the poor and the elderly.”

The pricing irregularities came to light as the result of whistleblower, Ven-A-Care of the Florida Keys, inc. The home-infusion company filed a claim under the False Claims Act against Aventis. Federal laws encourage and reward citizens and companies to report Medicaid fraud. Ven-A-Care received over $32 million for its whistleblower actions.

The Department Of Justice aggressively battles Medicaid fraud, keeping a particularly close watch on both healthcare providers as well as pharmaceutical companies. Both groups earn millions annually from the federal medical reimbursement programs.

Have information on Medicaid Fraud?

If you have information about Medicaid fraud, contact the Medicaid Fraud Reporting Center for a confidential claim evaluation today. You may report Medicaid fraud by completing the form on this page, or by calling our Medicaid Fraud Hotline at 1-800-934-2921.